Abstracts tagged "fibromyalgia"

Abstract Number: 1101 • 2017 ACR/ARHP Annual Meeting
Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability
Shakeel M. Jamal¹, Theodore Pincus², Isabel Castrejón², Jacquelin R. Chua¹, Aman Kugasia¹, Juan Schmukler¹, Stacy Weinberg¹ and Joel A. Block³, ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: A physician global estimate of patient status (DOCGL) on a 0-10 visual analog scales (VAS) is as effective as any rheumatoid arthritis (RA) Core…
Abstract Number: 2992 • 2017 ACR/ARHP Annual Meeting
Curbing the Opioid Epidemic: Predictors of Opioid Use in Juvenile Fibromyalgia Syndrome
Sabrina Gmuca¹, Rui Xiao², Andrea M. Knight³, David D. Sherry¹, Pamela F. Weiss⁴ and Jeffrey S. Gerber⁵, ¹Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ²Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³Division of Rheumatology, Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Division of Rheumatology, Center for Pediatric Clincial Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ⁵Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose: Despite the lack of evidence to support the use of opioids in the treatment of adult fibromyalgia syndrome, approximately 30% of patients receive an…
Abstract Number: 1247 • 2017 ACR/ARHP Annual Meeting
Coexisting Fibromyalgia in Patients with Rheumatoid Arthritis Worsens Scores for Pain, Physical Function and Depression
Dylan Ruebeck¹, Judith Baumhauer² and Allen P. Anandarajah³, ¹Internal Medicine, University of Rochester Medical Center, Rochester, NY, ²Orthopedics, University of Rochester Medical Center, rochester, NY, ³Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY
Background/Purpose: Quality of life (QOL) measures as assessed by Patient Reported Outcome Measurement Information System (PROMIS) can contribute essential information about the status of or…
Abstract Number: 1359 • 2017 ACR/ARHP Annual Meeting
M-DAS28, M-SDAI and M-CDAI Performance in a Cohort of RA Patients with and without Concomitant Fibromyalgia
Julia Sosa¹, Silvana Karina Pérez¹, Maria Julia Santa Cruz¹, María Alejandra Medina¹, Silvia Beatriz Papasidero¹, Diana Klajn², Jose Angel Caracciolo¹, María de los Angeles Correa³, Roger Rolón⁴, Gustavo Citera⁴, Maria Constanza Bertolaccini⁵, LL Gonzalez⁶, L Vargas⁷ and Oscar Rillo⁷, ¹Rheumatology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, ²Research Committee, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, ³Section Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Buenos Aires, Argentina, ⁴Rheumatology Department, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁵Rheumatology, Hospital Angel Cruz Padilla, Tucumán, Argentina, ⁶Hospital Angel Cruz Padilla, Tucumán, Argentina, ⁷Rheumatology Department, Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina
Background/Purpose: Fibromyalgia has been reported in approximately 20% of Rheumatoid Arthritis (RA) patients. Several studies have shown that the presence of Fibromyalgia (FM) is associated…
Abstract Number: 1653 • 2017 ACR/ARHP Annual Meeting
Factors Influencing on Health-Related Quality of Life in Female Systemic Lupus Erythematosus Patients with Fibromyalgia
Kyung Min Ko¹, Jun-Ki Min² and Su-Jin Moon³, ¹Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), ²Bucheon St. Mary's Hospital, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South), ³Bucheon St. Mary's Hospital, Division of rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Bucheon, Korea, Republic of (South)
Background/Purpose: Health-related quality of life (HRQoL) among systemic lupus erythematosus (SLE) patients is reduced, and fibromyalgia contribute to the decreased HRQoL. The objective of the…
Abstract Number: 1868 • 2017 ACR/ARHP Annual Meeting
Association between Brain-Derived Neurotrophic Factor Gene Polymorphisms and Fibromyalgia in a Korean Population: A Multi-Center Study
Ji-Hyoun Kang¹, Kyung-Eun Lee², Dong-Jin Park¹, Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim⁹, Hye-Soon Lee¹⁰, Hyoun-Ah Kim¹¹, Chung-Il Joung¹², Sang-Hyon Kim¹³ and Shin-Seok Lee¹, ¹Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ³Inje University Haeundae Paik Hospital, Busan, Korea, Republic of (South), ⁴Soonchunhyang University, College of Medicine, Cheonan, Korea, Republic of (South), ⁵Maryknoll Medical Center, Busan, Korea, Republic of (South), ⁶Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), ⁷Rheumatology, Kyung Hee University Hospital, Seoul, Korea, Republic of (South), ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, Korea, Republic of (South), ⁹Soonchenhyang university school of medicine, Seoul, Korea, Republic of (South), ¹⁰Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of (South), ¹¹Ajou University Hospital, Suwon, Korea, Republic of (South), ¹²Konyang University Medical School, Daejeon, Korea, Republic of (South), ¹³Division of Rheumatology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea, Daegu, Korea, Republic of (South)
Background/Purpose: Several lines of evidence suggest that brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of fibromyalgia (FM) and studies have found that FM…
Abstract Number: 52 • 2016 ACR/ARHP Annual Meeting
Pregabalin Dose-Response for Sleep Quality and Pain Response in Fibromyalgia: A Post-Hoc Analysis of Three Randomized Trials
Andrew Clair¹, Ed Whalen¹, Neal Thomas¹ and Lynne Pauer², ¹Pfizer, New York, NY, ²Pfizer, Groton, CT
Background/Purpose: Pregabalin is often administered for treatment of fibromyalgia (FM) at daily doses lower than approved by the US Food and Drug Administration (starting dose…
Abstract Number: 33 • 2016 ACR/ARHP Annual Meeting
Prevalence of Growth Hormone Deficiency in Fibromyalgia Patients
Thomas Romano, Private Practice, Martins Ferry, OH
Background/Purpose: Low levels of Insulin-dependent growth factor 1 (IGF-1) have been described in Fibromyalgia (FM) patients, suggesting that they have adult growth hormone (GH) deficiency.…
Abstract Number: 2200 • 2016 ACR/ARHP Annual Meeting
Association of Active Commuting and Physical Activity in Women with Fibromyalgia
Manuel Herrador-Colmenero¹, Fernando Estévez-López¹, Víctor Segura-Jiménez¹, Inmaculada C Álvarez-Gallardo¹, Alberto Soriano-Maldonado¹, Daniel Camiletti-Moirón^1,2, Virginia A Aparicio¹, Manuel Delgado-Fernández¹ and Palma Chillón¹, ¹University of Granada, Granada, Spain, ²University of Cádiz, Cádiz, Spain
Background/Purpose: Fibromyalgia symptomatology results in a low functional capacity1, limiting the daily activities and the quality of life of the patients2. Walking for commuting is…
Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting
Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research
Theodore Pincus¹, Isabel Castrejón¹, Joel Block² and Nathaniel Cook¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Division of Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…
Abstract Number: 42 • 2016 ACR/ARHP Annual Meeting
Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results
Euthalia Roussou¹, Johnathan Chan², Istvan Bodi³ and Aleksandar Radunivics², ¹Rheumatology, Dr, London, United Kingdom, ²Neurologist, London, United Kingdom, ³Department of Clinical Neuropathology, London, United Kingdom
Background/Purpose: To assess patients with primary fibromyalgia (pFM) for small fibre neuropathy (SFN) and to correlate biopsy results between groups and with known causes of…
Abstract Number: 2206 • 2016 ACR/ARHP Annual Meeting
Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)
José E. Martinez^1,2, Marcelo C. Rezende^1,3, Eduardo Paiva^1,4, Daniel Pollak^1,5, Milton Helfenstein Jr^1,6, Jose Roberto Provenza^1,7, Aline Ranzolin^1,8, Luiz Severiano Ribeiro^1,9, Eduardo J. R. Souza^1,10, Roberto E Heymann^1,11 and Marcos Renato Assis^1,12, ¹Brazilian Society of Rheumatology, São Paulo, Brazil, ²Rheumatology, Pontificia Universidade Católica de São Paulo, Sorocaba, Brazil, ³Santa Casa de Campo Grande, Campo Grande, Brazil, ⁴Rheumatology, Universidade Federal do Parana, Curitiba Parana, Brazil, ⁵Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, ⁶RUA JOAO DE LACERDA SOARES, 90, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁷Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, ⁸Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, ⁹Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, ¹⁰Santa Casa de Belo Horizonte, Belo Horizonte, Brazil, ¹¹Universidade Federal de São Paulo, São Paulo, Brazil, ¹²Rheumatology, Faculdade de Medicina de Marilia, Marilia, Brazil
Background/Purpose: The Brazilian registry on fibromyalgia syndrome (EpiFibro) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
Abstract Number: 44 • 2016 ACR/ARHP Annual Meeting
Ambroxol for Fibromyalgia. One-Group Pretest-Posttest Open Label Clinical Observation
Laura-Aline Martinez-Martinez¹, Luis-Fernando Perez², Gumaro Acosta², Lizbeth Becerril³, Pedro Rodriguez-Henriquez⁴, Omar-Eloy Muñoz-Monroy⁵, Luis H. Silveira⁶, Angelica Vargas Guerrero⁷ and Manuel Martínez-Lavín⁷, ¹Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, TX, Mexico, ²National Institute of Cardiology, Mexico, Mexico, ³Hospital Juarez, Mexico, Mexico, ⁴Rheumatology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, ⁵Hospital Militar, Mexico City, Mexico, ⁶Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, ⁷Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome. Moreover it has been suggested that dorsal root ganglia…
Abstract Number: 2217 • 2016 ACR/ARHP Annual Meeting
Adherence to Drug Therapy in Patients with Fibromyalgia
Guillermo Bennasar Sr.¹, Anastasia Secco² and Marta Mamani³, ¹Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ²Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ³Hospital Bernardino Rivadavia, Ciudad Autónoma de Buenos Aires, Argentina
Background/Purpose: As in other chronic diseases, adherence to the treatment regimen of patients with fibromyalgia (FM) is low (between 30 and 80%), depending on the…
Abstract Number: 48 • 2016 ACR/ARHP Annual Meeting
Fibromyalgia Impact Is a Potential Mediator for the Associations of Self-Efficacy and Pain Catastrophizing with Physical Functioning in Persons with Fibromyalgia
Sun Yu¹, Lori Lyn Price², Jeffrey B. Driban¹, William F. Harvey¹ and Chenchen Wang¹, ¹Rheumatology, Tufts Medical Center, Boston, MA, ²Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
Background/Purpose: Fibromyalgia (FM) is a chronic multidimensional disorder that causes physical and psychological impairment, incurring significant healthcare costs. Self-efficacy and pain catastrophizing have been shown…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].